A novel drug discovered by researchers from the University of Hong Kong was found effective in treating Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS) and A/H1N1 influenza, according to the university.
This case underscores the importance of a high index of suspicion of MERS-CoV infection in any febrile patients who present after a trip to the Middle East.
A South Korean couple has been put in quarantine after showing signs of Middle East respiratory syndrome (MERS), officials said December 23.
The new case raises the global total since the virus was first detected in humans in 2012 to 2,277, at least 806 of them fatal.
During the study, the use of personal protective equipment after the occurrence of Middle East respiratory syndrome (MERS) infections compared with the period before MERS infections increased dramatically from 2,947.4 to 10,283.9 per 1,000 patient-days for surgical masks and from 22 to 232 per 1,000 patient-days for N95 masks.
Scientists investigated virus mutations and found that certain mutations made the Middle East respiratory (MERS) virus more resistant against the human immune system. The analysis of mutations is essential for predicting the risk of a pandemic.
The Saudi Ministry of Health reports three Middle East respiratory syndrome (MERS) cases, one of which from Riyadh City is described as a `secondary, household contact.'
With the new cases, the total global number of laboratory-confirmed MERS-CoV (Middle East respiratory syndrome coronavirus) cases reported to WHO since 2012 is 2,262 with 803 associated deaths.
Using sensitive immunological assays and a cohort of camel workers with well-documented camel exposure, research showed that approximately 50 percent of camel workers in the Kingdom of Saudi Arabia and 0 percent of controls were previously infected.
Sixty high-level public health and Middle East respiratory syndrome (MERS) practitioners, researchers, and experts will meet to establish a pool of experts that can be deployed rapidly during any future outbreaks, as well as share and discuss the latest evidence, best practices, and lessons learned on MERS.